ReviewNature neuroscience2017
Whole genome sequencing in psychiatric disorders: the WGSPD consortium.
Erratum issuedAbstract readReview
In one paragraph
Review in Nature neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Long-Read sequencing in psychiatric omics: a systematic review of current evidence.Molecular psychiatry · 2026Pooled it
- The predictive value of polygenic risk scores for depression in gene-environment interaction studies: a systematic review.Translational psychiatry · 2026Pooled it
- A transdiagnostic network for psychiatric illness derived from atrophy and lesions.Nature human behaviour · 2023Pooled it
- Article
- Article
- Unraveling the enigma of mental disorders: a genetics-first approach and the role of mouse models based on rare disease-susceptible genome variants.Nagoya journal of medical science · 2025Review
- An integrative scoring approach for prioritization of rare autism spectrum disorder candidate variants from whole exome sequencing data.Scientific reports · 2025Article
- Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR libraries.Cell reports methods · 2024Article
- An Update on the Genetics of IgA Nephropathy.Journal of clinical medicine · 2023Review
- Rediscovering tandem repeat variation in schizophrenia: challenges and opportunities.Translational psychiatry · 2023Review
- Review
- Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays.International journal of molecular sciences · 2023Article
- Ten challenges for clinical translation in psychiatric genetics.Nature genetics · 2022Review
- Ultra-rare and common genetic variant analysis converge to implicate negative selection and neuronal processes in the aetiology of schizophrenia.Molecular psychiatry · 2022Article
- Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.Pharmaceutics · 2022Review
- The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.Nature communications · 2022Article
- Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Genomic and neuroimaging approaches to bipolar disorder.BJPsych open · 2022Review
- Validation of Candidate Sleep Disorder Risk Genes Using Zebrafish.Frontiers in molecular neuroscience · 2022Review
- Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels.PloS one · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
29 authors.
Stephan J SandersDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Benjamin M NealeAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1513-6077
Hailiang HuangAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1461-5762
Donna M WerlingDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Joon-Yong AnDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-8839-6297
Shan DongDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Whole Genome Sequencing for Psychiatric Disorders (WGSPD)
Goncalo AbecasisDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
P Alexander ArguelloNational Institute of Mental Health, Bethesda, MD, USA.ORCID 0000-0002-7709-8697
John BlangeroSouth Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, School of Medicine, Brownsville, TX, USA.
Michael BoehnkeDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Mark J DalyAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-0949-8752
Kevin EgganStanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Daniel H GeschwindDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
David C GlahnDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
David B GoldsteinInstitute for Genomic Medicine, Columbia University Medical Center, Hammer Health Sciences, New York, NY, USA.
Raquel E GurDepartment of Psychiatry, Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Robert E HandsakerStanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID 0000-0002-3128-3547
Steven A McCarrollStanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Roel A OphoffBrain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-8287-6457
Aarno PalotieStanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Carlos N PatoDepartment of Psychiatry, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Chiara SabattiDepartment of Health Research and Policy, Division of Biostatistics, Stanford University, Stanford, CA, USA.
Matthew W StateDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
A Jeremy WillseyDepartment of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Steven E HymanStanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA. seh@harvard.edu.ORCID 0000-0002-3628-2359
Anjene M AddingtonDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. anjene.addington@nih.gov.ORCID 0000-0001-7770-299X
Thomas LehnerDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. tlehner@mail.nih.gov.
Nelson B FreimerCenter for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA. nfreimer@mednet.ucla.edu.ORCID 0000-0003-3586-6587
Funding
Genomic Psychiatry CohortR01MH085548 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PATO, CARLOS N, PATO, MICHELE T · 2008 to 2012
$16.3MWhole Genome Sequencing for Schizophrenia and Bipolar Disorder in the GPCU01MH105641 · NIMH · BROAD INSTITUTE, INC. · PI MCCARROLL, STEVEN ANDREW · 2014 to 2018
$13.6M1/2 Genomic Strategies to Identify High-impact Psychiatric Risk VariantsU01MH105578 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B., GESCHWIND, DANIEL H · 2014 to 2018
$8.5M1/3-ldentifying regulatory mutations that influence neuropsychiatric diseaseU01MH105670 · NIMH · DUKE UNIVERSITY · PI GOLDSTEIN, DAVID B. · 2014 to 2018
$5.9M2/3-Identifying regulatory mutations that influence neuropsychiatric diseaseU01MH105575 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STATE, MATTHEW W. · 2014 to 2018
$5.7M3/3-Identifying regulatory mutations that influence neuropsychiatric diseaseU01MH105669 · NIMH · BROAD INSTITUTE, INC. · PI DALY, MARK JOSEPH · 2014 to 2018
$4.5M2/3: Pedigree-Based Whole Genome Sequencing of Affective and Psychotic DisordersU01MH105632 · NIMH · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI BLANGERO, JOHN · 2015 to 2018
$4.2M4/4 The Autism Sequencing Consortium: Autism gene discovery in the >20,000 exomes (supplement)U01MH100239 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STATE, MATTHEW W. · 2013 to 2015
$3.0MWhole Genome Sequencing for Schizophrenia and Bipolar Disorder in the GPCU01MH105653 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L · 2014 to 2018
$2.8MGenome Sequencing in Extended Bipolar PedigreesR01MH095454 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B. · 2012 to 2014
$2.4M1/3:Pedigree-Based Whole Genome Sequencing of Affective and Psychotic DisordersU01MH105630 · NIMH · YALE UNIVERSITY · PI GLAHN, DAVID C · 2015 to 2018
$1.4M2/2 Genomic strategies to identify high-impact psychiatric risk variantsU01MH105666 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PALOTIE, AARNO · 2014 to 2018
$1.0MNIMH NIH HHS R01 MH085548NIMH NIH HHS R01 MH095454NIMH NIH HHS U01 MH100239NIMH NIH HHS U01 MH105573NIMH NIH HHS U01 MH105575NIMH NIH HHS U01 MH105578NIMH NIH HHS U01 MH105630NIMH NIH HHS U01 MH105632NIMH NIH HHS U01 MH105634NIMH NIH HHS U01 MH105641NIMH NIH HHS U01 MH105653NIMH NIH HHS U01 MH105666NIMH NIH HHS U01 MH105669NIMH NIH HHS U01 MH105670
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biological PsychiatryGenetic VariationGenome, HumanHumansMental DisordersWhole Genome Sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.